GANX – gain therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Gain Therapeutics To Present At Biotech Showcase 2025 [Yahoo! Finance]
Gain Therapeutics To Present At Biotech Showcase 2025
Gain Therapeutics, Inc. (NASDAQ: GANX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Gain Therapeutics, Inc. (NASDAQ: GANX) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $7.00 price target on the stock.
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
Form 8-K Gain Therapeutics, Inc. For: Nov 14
Form 8-K Gain Therapeutics, Inc. For: Oct 21
Form 8-K Gain Therapeutics, Inc. For: Oct 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.